AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 282: F191-F201, 2002. First published August 30, 2001; doi:10.1152/ajprenal.0197.2001
0363-6127/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/F191    most recent
0197.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (63)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Iturbe, B.
Right arrow Articles by Pons, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Iturbe, B.
Right arrow Articles by Pons, H. A.
Vol. 282, Issue 2, F191-F201, February 2002

Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats

Bernardo Rodríguez-Iturbe1, Yasmir Quiroz1, Mayerly Nava1, Lizzette Bonet1, Maribel Chávez1, Jaime Herrera-Acosta2, Richard J. Johnson3, and Héctor A. Pons1

1 Renal Service and Laboratory, Hospital Universitario, Instituto de Investigaciones Biomédicas, Universidad del Zulia, Maracaibo, Zulia 4001-A, Venezuela; 2 Department of Nephrology, Instituto de Cardiología, Mexico City, Tlalpan 14080, Mexico; and 3 Renal Division, Baylor Medical College, Houston, Texas 770030

Immunocompetent cells infiltrate the kidney in several models of experimental hypertension. We have previously shown that reduction of this infiltrate results in prevention of salt-sensitive hypertension induced by short-term angiotensin II infusion and nitric oxide inhibition (Quiroz Y, Pons H, Gordon KI, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, Johnson RJ, and Rodríguez-Iturbe B. Am J Physiol Renal Physiol 281: F38-F47, 2001; Rodríguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Largo R, Egido J, and Johnson RJ. Kidney Int 59: 2222-2232, 2001). We therefore studied whether hypertension could be controlled in genetically hypertensive rats [spontaneously hypertensive rats (SHR)] by the administration of 20 mg · kg-1 · day-1 of the immunosuppressive drug mycophenolate mofetil (MMF group; n = 35). Other SHR received vehicle (n = 35), and Wistar-Kyoto rats (n = 20) were used as controls. MMF or vehicle was given in two separate 4-wk periods, separated by a 3-wk interval. Systemic hypertension was reduced to normal levels in both periods of MMF treatment in association with a reduction in lymphocyte, macrophage, and angiotensin II-positive cells infiltrating the kidney. Oxidative stress was also reduced by MMF, as indicated by a reduction in urinary malondialdehyde (MDA), renal MDA content, and superoxide-positive cells, and was highly correlated with blood pressure levels. We conclude that the renal immune infiltrate plays a major role in the hypertension in SHR.

immune cells; spontaneously hypertensive rats; mycophenolate mofetil; oxidative stress


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Wang and D. H. Wang
Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension
Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1550 - F1559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. Elks, N. Mariappan, M. Haque, A. Guggilam, D. S. A. Majid, and J. Francis
Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR
Am J Physiol Renal Physiol, February 1, 2009; 296(2): F298 - F305.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T.-D. Liao, X.-P. Yang, Y.-H. Liu, E. G. Shesely, M. A. Cavasin, W. A. Kuziel, P. J. Pagano, and O. A. Carretero
Role of Inflammation in the Development of Renal Damage and Dysfunction in Angiotensin II-Induced Hypertension
Hypertension, August 1, 2008; 52(2): 256 - 263.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Helmut
T-cells in angiotensin-II-induced vascular damage
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1107 - 1108.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Quiroz, A. Ferrebuz, F. Romero, N. D. Vaziri, and B. Rodriguez-Iturbe
Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F336 - F344.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. L. Graciano, A. Nishiyama, K. Jackson, D. M. Seth, R. M. Ortiz, M. C. Prieto-Carrasquero, H. Kobori, and L. G. Navar
Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F161 - F169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Tian, R. S. Moore, S. Braddy, R. A. Rose, J.-W. Gu, M. D. Hughson, and R. D. Manning Jr.
Interactions between oxidative stress and inflammation in salt-sensitive hypertension
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3388 - H3395.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. J. Guzik, N. E. Hoch, K. A. Brown, L. A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D. G. Harrison
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction
J. Exp. Med., October 1, 2007; 204(10): 2449 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Bravo, Y. Quiroz, A. Ferrebuz, N. D. Vaziri, and B. Rodriguez-Iturbe
Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F616 - F623.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Franco, F. Martinez, Y. Quiroz, O. Galicia, R. Bautista, R. J. Johnson, and B. Rodriguez-Iturbe
Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R251 - R256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. R. Spurgeon-Pechman, D. L. Donohoe, D. L. Mattson, H. Lund, L. James, and D. P. Basile
Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F269 - F278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. L. Graciano, C. R. Mouton, M. E. Patterson, D. M. Seth, J. J. Mullins, and K. D. Mitchell
Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1858 - F1866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. K. Fujihara, D. M. A. C. Malheiros, and R. Zatz
Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1810 - F1818.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Yu, R. Gong, A. Rifai, E. M. Tolbert, and L. D. Dworkin
Long-Term, High-Dosage Candesartan Suppresses Inflammation and Injury in Chronic Kidney Disease: Nonhemodynamic Renal Protection
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 750 - 759.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. Rodriguez-Iturbe, L. Sepassi, Y. Quiroz, Z. Ni, and N. D. Vaziri
Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence
J Appl Physiol, January 1, 2007; 102(1): 255 - 260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J.-W. Gu, N. Tian, M. Shparago, W. Tan, A. P. Bailey, and R. D. Manning Jr.
Renal NF-{kappa}B activation and TNF-{alpha} upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1817 - R1824.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Franco, F. Martinez, B. Rodriguez-Iturbe, R. J. Johnson, J. Santamaria, A. Montoya, T. Nepomuceno, R. Bautista, E. Tapia, and J. Herrera-Acosta
Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1281 - F1287.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Herrera, A. Ferrebuz, E. G. MacGregor, and B. Rodriguez-Iturbe
Mycophenolate Mofetil Treatment Improves Hypertension in Patients with Psoriasis and Rheumatoid Arthritis
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S218 - S225.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
S I van Leuven, J J P Kastelein, M R Hayden, and E S Stroes
Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?
Lupus, November 1, 2006; 15(11_suppl): 11 - 17.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Rodriguez-Iturbe and R. J. Johnson
Role of inflammatory cells in the kidney in the induction and maintenance of hypertension
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 260 - 263.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Wilcox
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. R. R. Goncalves, C. K. Fujihara, A. L. Mattar, D. M. A. C. Malheiros, I. L. Noronha, G. de Nucci, and R. Zatz
Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory
Am J Physiol Renal Physiol, May 1, 2004; 286(5): F945 - F954.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. Rodriguez-Iturbe, N. D. Vaziri, J. Herrera-Acosta, and R. J. Johnson
Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all
Am J Physiol Renal Physiol, April 1, 2004; 286(4): F606 - F616.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Nava, Y. Quiroz, N. Vaziri, and B. Rodriguez-Iturbe
Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats
Am J Physiol Renal Physiol, March 1, 2003; 284(3): F447 - F454.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Zatz, I. L. Noronha, and C. K. Fujihara
Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies
Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1167 - F1175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. Alvarez, Y. Quiroz, M. Nava, H. Pons, and B. Rodriguez-Iturbe
Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells
Am J Physiol Renal Physiol, November 1, 2002; 283(5): F1132 - F1141.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online